About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 5,491–5,500 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 5,426 |
Cambridge Prisms-Global Mental Health CAMB PRISM-GLOB MENT |
2054-4251 2054-4251 |
2.800 | 2.800 | Q2 | 106/288 | CAMBRIDGE UNIV PRESS |
| 5,426 |
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE CAN J OPHTHALMOL |
0008-4182 1715-3360 |
2.800 | 2.500 | Q1 | 23/98 | CANADIAN OPHTHAL SOC |
| 5,426 |
Cancer Pathogenesis and Therapy CANCER PATHOG THER |
2097-2563 2949-7132 |
2.800 | 2.800 | Q2 | 160/326 | ELSEVIER |
| 5,426 |
Cerebral Circulation-Cognition and Behavior CEREB CIRC-COGN BEHA |
2666-2450 2666-2450 |
2.800 | 2.600 | Q2 | 37/98 | ELSEVIER |
| 5,426 |
CHEMBIOCHEM CHEMBIOCHEM |
1439-4227 1439-7633 |
2.800 | 3.000 | Q3 | 187/319 | WILEY-V C H VERLAG GMBH |
| 5,426 |
CHEMISTRY AND PHYSICS OF LIPIDS CHEM PHYS LIPIDS |
0009-3084 1873-2941 |
2.800 | 3.100 | Q2 | 32/79 | ELSEVIER IRELAND LTD |
| 5,426 |
ChemPlusChem CHEMPLUSCHEM |
2192-6506 2192-6506 |
2.800 | 3.000 | Q2 | 114/239 | WILEY-V C H VERLAG GMBH |
| 5,426 |
Chinese Optics Letters CHIN OPT LETT |
1671-7694 1671-7694 |
2.800 | 2.200 | Q2 | 56/125 | CHINESE LASER PRESS |
| 5,426 |
CHROMOSOME RESEARCH CHROMOSOME RES |
0967-3849 1573-6849 |
2.800 | 2.800 | Q2 | 79/191 | SPRINGER |
| 5,426 |
CLINICAL AND EXPERIMENTAL DERMATOLOGY CLIN EXP DERMATOL |
0307-6938 1365-2230 |
2.800 | 3.200 | Q2 | 31/96 | OXFORD UNIV PRESS |